University Hospital of Ioannina COVID-19 (Coronavirus Disease 2019) Registry

Sponsor
University Hospital, Ioannina (Other)
Overall Status
Recruiting
CT.gov ID
NCT05534074
Collaborator
1st Division of Internal Medicine, University Hospital of Ioannina (Other)
2,500
1
58.1
43.1

Study Details

Study Description

Brief Summary

COVID-19 (Coronavirus Disease 2019) Registry of University Hospital of Ioannina. Retrospective datasource registry with quantitative and qualitative patient data from the hospital medical records. Epidemiological, clinical and laboratory parameters are recorded on 7 different time points (day: 1, 3, 5, 7, 9, 11, 15) concerning 793 variables of interest in an electronic (computerised) database. Patients are also followed-up after 90 days from hospital discharge (number of visits of follow-up depends on patient's health status) at the Post-COVID and Long-term effects of coronavirus (long COVID) outpatient clinic of University Hospital of Ioannina. Data from this outpatient clinic are also recorded in an electronic database (189 variables of concern for each patient)

Detailed Description

This is a retrospective study of COVID-19 (Coronavirus Disease 2019) at the Infectious Diseases Unit of the University Hospital of Ioannina. Quantitative and qualitative patient data are collected from the hospital medical records. Epidemiological, clinical and laboratory parameters are recorded on 7 different time points (day: 1, 3, 5, 7, 9, 11, 15) concerning 793 variables of interest in an electronic (computerised) database. Patients are also followed-up after 90 days from hospital discharge (number of visits of follow-up depends on patient's health status) at the Post-COVID and Long-term effects of coronavirus (long COVID) outpatient clinic of University Hospital of Ioannina. Data from this outpatient clinic are also recorded in an electronic database (189 variables of concern for each patient) The investigators collect data from COVID-19 hospitalized patients in the Infectious Diseases Unit of the University Hospital of Ioannina, from March 1st 2020 and ongoing. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection was diagnosed by reverse real time transcription-polymerase chain reaction (RT-PCR) test performed on nasopharyngeal swab specimens. Data are obtained retrospectively using patients' medical records (hard copy and digital records). All medical records are imported in a digital database anonymously with a personal identifier code for each patient, as prespecified by study protocol.

All data are collected following the highest standards set by the respective European Guidelines for Good Clinical and Laboratory Practice in Research Studies/Protocols and in accordance with the Helsinki Declaration. All participants in the study receive a personal identifier code and are kept anonymous. The epidemiological, clinical and laboratory data are collected and stored without being linked to personal data of the patients, but only to the personal identifier code. Biological samples are not collected. The collected clinical and laboratory data are archived in electronic databases (793 variables of concern for each individual patient).

Study Design

Study Type:
Observational [Patient Registry]
Anticipated Enrollment :
2500 participants
Observational Model:
Cohort
Time Perspective:
Other
Official Title:
University Hospital of Ioannina COVID-19 Registry. Retrospective Datasource Registry of COVID-19 (Coronavirus Disease 2019) Hospitalized Patients
Actual Study Start Date :
Mar 1, 2020
Anticipated Primary Completion Date :
Dec 31, 2024
Anticipated Study Completion Date :
Jan 1, 2025

Outcome Measures

Primary Outcome Measures

  1. association of indices of COVID-19 severity with outcomes [5 years]

    outcomes: respiratory failure, disease severity in CT, death, intubation, length of stay

Eligibility Criteria

Criteria

Ages Eligible for Study:
16 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • PCR positive for SARS-CoV-2

  • hospitalization for COVID-19 disease in the Infectious Diseases Unit of University Hospital of Ioannina, greece

Exclusion Criteria:
  • none

Contacts and Locations

Locations

Site City State Country Postal Code
1 1st Division of Internal Medicine and Infectious Diseases Unit, University Hospital of Ioannina Ioánnina Epirus Greece 45500

Sponsors and Collaborators

  • University Hospital, Ioannina
  • 1st Division of Internal Medicine, University Hospital of Ioannina

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

None provided.
Responsible Party:
Liontos Angelos, Assistant Consultant of Internal Medicine, University Hospital, Ioannina
ClinicalTrials.gov Identifier:
NCT05534074
Other Study ID Numbers:
  • 4/21-4-2021 (Issue 24)
  • 2022-003051-33
  • U1111-1282-3362
  • ΑΔΑ: Ψ29Ψ46906Η-9Τ0
  • ΑΔΑ: Ψ29Ψ46906Η-9Τ0
First Posted:
Sep 9, 2022
Last Update Posted:
Sep 14, 2022
Last Verified:
Sep 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Liontos Angelos, Assistant Consultant of Internal Medicine, University Hospital, Ioannina
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 14, 2022